Login

A RADICAL INVESTMENT PLATFORM RESHAPING THE RELATIONSHIP BETWEEN FOUNDERS AND CAPITAL|Khaled Talhouni, Managing Partner, Nuwa Capital 00:10:00

Share On Facebook Share On Twitter

Venture Capitalist investing in emerging markets

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Callitas Health Inc. CEO James Thompson Discusses Upcoming Launch of CannaMint Strips and New Partnership for Arousal Gels
00:10:00
BlackLine's Founder Therese Tucker Reflects on 20 Years as CEO | Therese Tucker, CEO, BlackLine Inc.
00:00:00
Pediatric Brain Tumor - David J. Daniels, M.D., Ph.D.
00:10:00
Duck Creek CEO Mike Jackowski appears on "Squawk Alley" to share insights on the company's outlook following its IPO.|Michael Jackowski, CEO of Duck Creek Technologies,
00:10:00
Investment firm that believes the power in venture capital |Mallun Yen, CEO,Operator Collective
00:10:00
Adapting to New Business Realities in South Africa: Challenges and Resilience Amid Logistics and Energy Constraints|DR NOMBASA TSENGWA,CHIEF EXECUTIVE OFFICER,Exxaro Resources Ltd.
00:00:00
Jarrod Ritchie, CEO, TPI Enterprises Ltd
00:10:00
Safeguarding Wealth: Leveraging Precious Metals for Stability in Volatile Markets | Financial Insights on Portfolio Diversification
00:10:00
Analyzing the Federal Reserve's Landing and Economic Outlook | Scott Sperling, CO-CEO, Thomas H. Lee Partners .
00:10:00
We are Committed to making the world a better place|Hans Vestberg,Chairman,Verizon Asset Management Corp.
00:10:00
American Airlines CEO Robert Isom on Innovation and the Future | Robert Isom, CEO, American Airlines Group Inc.
00:10:00
Sitowise's Leadership Transition: Reflections on 2021 and Future Outlook | Heikki Haasma, CEO, Sitowise Group Oyj.

© 2017 - Neuhu+